Amyris Inc. [NASDAQ: AMRS] surged by $0.7 during the normal trading session on Wednesday and reaching a high of $16.24 during the day while it closed the day at $16.06. The company report on April 14, 2021 that Amyris To Acquire Beauty Labs Combining Clean Beauty Leadership With Digital Innovation.
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced that it has agreed to acquire Beauty Labs International Ltd. (“Beauty Labs”), a leader in AI technology that provides breakthrough connected consumer experiences to the beauty and wellness community.
Amyris is accelerating its growth and market leadership in clean beauty by adding digital innovation to further enhance the consumer experience of its family of consumer brands consisting of Biossance®, Pipette®, Rose Inc., JVN, Terasana, and Costa Brazil. These Amyris brands will utilize Beauty Labs’ leading edge AI technology to create compelling, personalized, connected consumer experiences and further accelerate the growth of Amyris’s ecommerce revenue.
Amyris Inc. stock has also loss -4.83% of its value over the past 7 days. However, AMRS stock has inclined by 71.71% in the 3 months of the year. Over the past six months meanwhile, it has gained 433.39% and gained 160.00% year-on date.
The market cap for AMRS stock reached $4.24 billion, with 246.82 million shares outstanding and 154.20 million shares in the current float. Compared to the average trading volume of 5.15M shares, AMRS reached a trading volume of 5371795 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Amyris Inc. [AMRS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRS shares is $26.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRS stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Amyris Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 03, 2021. While these analysts kept the previous recommendation, ROTH Capital raised their target price to Buy. The new note on the price target was released on February 26, 2021, representing the official price target for Amyris Inc. stock. Previously, the target price had yet another raise to $9, while Cowen analysts kept a Outperform rating on AMRS stock.
The Average True Range (ATR) for Amyris Inc. is set at 1.83, with the Price to Sales ratio for AMRS stock in the period of the last 12 months amounting to 24.51.
AMRS stock trade performance evaluation
Amyris Inc. [AMRS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.83. With this latest performance, AMRS shares dropped by -28.13% in over the last four-week period, additionally plugging by 433.39% over the last 6 months – not to mention a rise of 573.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRS stock in for the last two-week period is set at 44.20, with the RSI for the last a single of trading hit 39.83, and the three-weeks RSI is set at 47.64 for Amyris Inc. [AMRS]. The present Moving Average for the last 50 days of trading for this stock 16.95, while it was recorded at 15.92 for the last single week of trading, and 7.42 for the last 200 days.
Amyris Inc. [AMRS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Amyris Inc. [AMRS] shares currently have an operating margin of -71.29 and a Gross Margin at +45.83. Amyris Inc.’s Net Margin is presently recorded at -182.03.
Additionally, AMRS Total Debt to Total Capital is recorded at 255.68, with Total Debt to Total Assets ending up at 126.65.
Reflecting on the efficiency of the workforce at the company, Amyris Inc. [AMRS] managed to generate an average of -$529,681 per employee. Receivables Turnover for the company is 4.32 with a Total Asset Turnover recorded at a value of 0.90.Amyris Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.90.
Earnings per share (EPS) analysis for Amyris Inc. [AMRS] stock
With the latest financial reports released by the company, Amyris Inc. posted -0.56/share EPS, while the average EPS was predicted by analysts to be reported at -0.19/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -194.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amyris Inc. go to 30.00%.
Amyris Inc. [AMRS]: Insider Ownership positions
There are presently around $1,594 million, or 38.30% of AMRS stock, in the hands of institutional investors. The top three institutional holders of AMRS stocks are: FMR LLC with ownership of 18,442,566, which is approximately 12.211% of the company’s market cap and around 31.11% of the total institutional ownership; FARALLON CAPITAL MANAGEMENT LLC, holding 17,500,000 shares of the stock with an approximate value of $280.96 million in AMRS stocks shares; and VIVO CAPITAL, LLC, currently with $211.31 million in AMRS stock with ownership of nearly 0.022% of the company’s market capitalization.
Positions in Amyris Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 94 institutional holders increased their position in Amyris Inc. [NASDAQ:AMRS] by around 22,074,845 shares. Additionally, 35 investors decreased positions by around 26,597,143 shares, while 19 investors held positions by with 50,619,434 shares. The mentioned changes placed institutional holdings at 99,291,422 shares, according to the latest SEC report filing. AMRS stock had 42 new institutional investments in for a total of 7,273,068 shares, while 19 institutional investors sold positions of 18,818,609 shares during the same period.